bioMérieux is a French multinational biotechnology company specialising in in vitro diagnostics. Founded in 1963, the company develops diagnostic systems, reagents, and software for pathogen detection, antimicrobial stewardship, sepsis management, food safety, and pharmaceutical quality control. Its solutions serve the healthcare, hospital and laboratory, point-of-care, food safety, and pharmaceutical industries.
The company maintains operations in 45 countries and serves customers across 160 countries. Its technology stack spans comprehensive diagnostic platforms for clinical and industrial applications, including decision-support software for diagnostic analysis.
bioMérieux is a family-owned company. It describes itself as driven by an entrepreneurial culture and a commitment to improving public health worldwide. Headquartered in France, the firm has been active in the diagnostics space for over six decades.
